Skip to main content
Top
Published in: AIDS and Behavior 6/2015

01-06-2015 | Erratum

Erratum to: Neighborhood Condition and Geographic Locale in Assessing HIV/STI Risk Among African American Adolescents

Authors: Jelani C. Kerr, Robert F. Valois, Arjumand Siddiqi, Peter Vanable, Michael P. Carey, Ralph J. DiClemente, Daniel Romer, Larry K. Brown, Naomi B. Farber, Laura F. Salazar

Published in: AIDS and Behavior | Issue 6/2015

Login to get access

Excerpt

The names of the five co-authors Ralph J. DiClemente, Daniel Romer, Larry K. Brown, Naomi B. Farber, Laura F. Salazar were inadvertently omitted in the original publication. The correct order of authors and the affiliation are given in this erratum. An updated acknowledgement is also given below: …
Metadata
Title
Erratum to: Neighborhood Condition and Geographic Locale in Assessing HIV/STI Risk Among African American Adolescents
Authors
Jelani C. Kerr
Robert F. Valois
Arjumand Siddiqi
Peter Vanable
Michael P. Carey
Ralph J. DiClemente
Daniel Romer
Larry K. Brown
Naomi B. Farber
Laura F. Salazar
Publication date
01-06-2015
Publisher
Springer US
Published in
AIDS and Behavior / Issue 6/2015
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-014-0912-y

Other articles of this Issue 6/2015

AIDS and Behavior 6/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine